Sanofi recall of Auvi-Q Auto-injectors to cost $110m, page-3

Good point re costing them but Sanofi's free cash flow is in the $B, so $100m is not going to be a huge issue IMO especially if the quality of auto-injectors they replace it with will hopefully avoid this issue.

On a related topic, I was thinking about the AbbVie payment due in Q2 of $1.2m.

Using mdys post #14805305 - $1.2m divided by $350 per LISA = 3,429 units.

Not a huge amount though better than nothing.

Let me know if I'm missing something.